<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="85742">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02001350</url>
  </required_header>
  <id_info>
    <org_study_id>CIB-USG.GDA.PL</org_study_id>
    <nct_id>NCT02001350</nct_id>
  </id_info>
  <brief_title>Carotid Ultrasound Study</brief_title>
  <official_title>Carotid Ultrasound Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Noblewell</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cibiem, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Noblewell</source>
  <oversight_info>
    <authority>Poland: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To use carotid ultrasound to screen 20-30 patients with longstanding or resistant
      hypertension for carotid atherosclerotic disease and bifurcation anatomy. This will
      establish a screening protocol for Cibiem's eventual endovascular carotid body modulation
      trial and will give insight into the prevalence and specific location of carotid plaque at
      the bifurcation in this patient population.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>Specific location of carotid plaque at the bifurcation</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Resistant Hypertension</condition>
  <arm_group>
    <arm_group_label>Resistant hypertension</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ultrasonography</intervention_name>
    <arm_group_label>Resistant hypertension</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        30 patients with longstanding or resistant hypertension
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-75 years old

          -  Uncontrolled hypertension on 3 or more medications or longstanding controlled
             hypertension on 4 or more medications.

        Exclusion Criteria:

          -  Previous stroke

          -  Carotid endarterectomy or carotid stent procedure

          -  &gt;50% stenosis anywhere in carotid arteries
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul A. Sobotka, MD</last_name>
    <role>Study Director</role>
    <affiliation>Cibiem, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Krzysztof Narkiewicz, Prof.</last_name>
    <phone>0048583492527</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Hypertension and Diabetology, Medical University of Gdansk</name>
      <address>
        <city>Gdansk</city>
        <zip>80-952</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krzysztof Narkiewicz, Prof.</last_name>
      <phone>0048583492527</phone>
    </contact>
    <investigator>
      <last_name>Krzysztof Narkiewicz, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 27, 2013</lastchanged_date>
  <firstreceived_date>November 22, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
